a negative polymerase chain reaction (PCR) result for HIV at 6 weeks) were 5.1, 6.7, and 10.5 infections per 100 child-years of breast-feeding for infants who were EBF, predominantly breast-fed (feeding breast milk and other nonmilk liquids), and MBF, respectively, suggesting that even water and other nonmilk liquids increase postnatal risk, compared with strict EBF [3] .
The protection afforded by EBF against HIV transmission remains unexplained. Only 1 published report includes data on breast-feeding exclusivity, mastitis, and breast milk HIV load [5] . In that study, breast milk HIV load concentrations were unexpectedly higher in mothers practicing EBF, compared with MBF, at 14 weeks postpartum, with no association at earlier time points.
One hypothesis has been that EBF reduces the infant's vulnerability to HIV transmission because MBF and predominantly breast-feeding are associated with a greater risk of diarrhea [6] , which is associated with increased intestinal permeability [7] . However, this measure was not different between EBF and MBF infants in South Africa [8] . Another hypothesis put forth is that the immunologic make-up of breast milk or the infants immune status is adversely affected by mixed breast-feeding [9] .
Another possible explanation is that MBF infants are partially satiated by non-breast milk food consumption and suckle less vigorously, resulting in milk stasis in the breast, breast engorgement, and mastitis [10] . Both clinical [11] [12] [13] and subclinical mastitis [14, 15] , as indicated by elevated breast milk sodium/ potassium ratio or lactoferrin concentration, are associated with higher breast milk HIV load and breast-feeding-associated HIV transmission rates. The ratio of extracellular ions (sodium) to intracellular ions (potassium) becomes elevated when cell membranes are disrupted, which may also facilitate greater leakage of HIV from plasma to breast milk. Although clinical mastitis is a relatively rare condition [16] , as much as 50% of all breastfeeding-associated transmission may be attributable to subclinical mastitis [17] . However, mastitis may also provide protective effects; a recent study showed that mastitis is associated with increased concentrations of a-defensins, an anti-HIV peptide released by the innate immune system [18] . Importantly, mastitis is preventable by good lactation practices; Bangladeshi mothers who received counseling encouraging them to practice EBF and demonstration of correct positioning and attachment had lower breast milk sodium/potassium ratios than mothers who had not received the counseling [19] . In this analysis, we tested the hypothesis that the protective effect of EBF on mother-to-child HIV transmission is mediated by a reduction in mastitis.
METHODS
Participants and data collection. We used data and archived plasma and breast milk samples collected during the ZVI- [20, 21] . Mothers were enrolled and tested for HIV infection within 96 h of delivery (baseline) by 2 enzyme-linked immunosorbent assays (ELISAs) run in parallel (HIV 1.0.2 ICE; Murex Diagnostics and GeneScreen HIV 1/2; Sanofi Diagnostics Pasteur), with discordant ELISA results resolved by Western Blot (HIV Blot 2.2; Genelabs Diagnostics SA). Baseline characteristics were collected by questionnaire and transcription from hospital records. Gestational age was estimated [22] . Infant birth weight (Seca Model 727) and maternal mid-upper arm circumference were measured [23] . For HIV-positive mothers, CD4 cells were enumerated using a Facscount (Becton Dickinson International) within 48 h of phlebotomy. Hemoglobin was measured at baseline for women enrolled after 1 October 1998 (∼60% of the total sample) with use of a hemoglobinometer (HemoCue) on the day of specimen collection. Mother-infant pairs were followed up at 6 weeks, 3 months, and every 3 months for up to 24 months, as detailed elsewhere [20] . At each visit, maternal and infant blood and breast milk samples were collected.
In response to changes in international guidance on HIV and infant feeding, an education and counseling program was implemented within the ZVITAMBO trial to inform and support mothers in making and implementing infant feeding decisions beginning in September 1999 [24] .
Infant HIV status was determined after all patient contact was completed; the last available specimen was tested (plasma samples were tested by GeneScreen ELISA for samples collected at у18 months, or cell pellets were tested by prototype Roche Amplicor version 1.5 qualitative PCR assay [Roche Diagnostic Systems] for samples collected at !18 months). If this sample yielded negative results, the child was classified as uninfected; if results were positive, earlier samples were tested to determine timing of infection.
For the purpose of the current analysis, we selected motherinfant pairs on the basis of the following criteria: (1) the mother was HIV-positive at delivery, (2) the infant was HIV-negative by PCR at 6 weeks, and (3) the mother practiced either EBF or MBF (not predominantly breast-feeding) during the first 3 months postpartum ( Figure 1 ). All of the 155 EBF mother-infant pairs who met the criteria were selected; 5 of these infants were postnatally infected by 12 months of age. Among the 1414 NOTE. CI, confidence interval; EBF, exclusive breast-feeding; K, potassium; MBF, mixed breast-feeding; Na, sodium MBF mothers, 159 infants became infected postnatally, and all of these were selected. From the 1224 mothers whose infant remained uninfected during the course of the trial, a 20% subsample (245) was randomly selected using a random number list generated using SAS, version 9.1 (SAS Institute). Thus, a total of 559 mother-infant pairs were included. Predominantly breast-feeding mothers were excluded from this analysis because the difference in transmission rate between EBF and predominantly breast-fed infants was smaller than that between EBF and MBF, so we surmised that the difference in mastitis rates might also be smaller and require a larger sample size to detect [3] . In addition, we excluded 810 mother-infant pairs whose feeding pattern could not be characterized because of incomplete feeding information. Plasma and breast milk HIV load testing. HIV RNA loads were determined by the AMPLICOR Monitor kit, version 1.5 (Roche Diagnostics), in baseline maternal plasma with use of the regular procedure (detection limit, 200 copies/mL) and in breast milk supernatant with use of the ultrasensitive procedure (detection limit, 40 copies/mL) in our laboratory in Harare, Zimbabwe.
Sodium and potassium measurement. Sodium (Na) and potassium (K) concentrations in breast milk supernatant were determined using an Instrumentation Laboratories IL943 flame photometer. Six quality control samples were tested at the London School of Hygiene and Tropical Medicine by Dr Suzanne Filteau, to assess the accuracy of our measurements. There was no difference between 5 of the samples, and the mean values for the sixth were within 2 standard deviations of the result obtained in London. On the basis of previous reports [25, 26] , we considered a breast milk Na/K ratio 10.60 to define mastitis.
Infant feeding practices. At baseline, 6 weeks, and 3 months, mothers were asked whether any of 22 liquids, medicines, or solid foods had ever been fed to their infant since birth. Breast-feeding patterns were classified according to World Health Organization guidelines [27] and as described elsewhere [3] . Infants were classified as EBF to 3 months if they consumed only breast milk and prescribed medicines and vitamins at all 3 time points; 1 lapse in EBF was allowed but only if the nonbreast milk food was non-animal milk liquid. Infants were classified as MBF if they consumed breast milk plus nonhuman milks or solid foods at any of the 3 time points. Breastfeeding exclusivity was defined only for the first 3 months, because by 6 months only 68 babies (2.3%) were still exclusively breast-fed.
Statistical analysis. Plasma and breast milk HIV load data and breast milk Na/K ratio were normalized with a log 10 transformation. Bivariate comparisons for each baseline characteristic were performed using t tests for continuous variables and x 2 tests for categorical comparisons. Data for nontransmitting MBF mothers were weighted 5:1 to the other observations to compensate for the 20% subsampling of this group. Statistical analysis was conducted using SAS, version 9.1 (SAS Institute). Standard errors for categorical analyses and logistic regressions were calculated using PROC GENMOD with the "repeated subjects" statement to adjust for the artificially low standard errors resulting from weighting (in effect "repeating") the nontransmitting MBF mothers. Linear regression with step-wise selection was used to determine the independent predictors of log 10 breast milk HIV load at 6 weeks and at 3 and 6 months. We used discrete survival models based on person-days (using a complementary log-log link [28] ), because these are analogous to Cox proportional hazards models using the "exact" methods for ties but accommodate weighted data. We investigated the effect on postnatal transmission of breast-feeding exclusivity, mastitis, both plasma and breast milk HIV load, and the interaction between mastitis and plasma HIV load, with and without adjusting for other explanatory variables. The date of transmission was estimated as the midpoint between the last negative and the first positive HIV test. In addition to the main variables of interest, the following were included in models of transmission to control for factors related to maternal and infant health: maternal education !8 years, primiparity, previous child death, infant birth weight !2500 g, maternal CD4 count, and maternal hemoglobin level at recruitment. All transmission models included a categorical variable for the date of recruitment to control for the effect of the passage of calendar time. Maternal CD4 cell count and hemoglobin measurements were analyzed as categorical variables (!350 cells/mL, у350 cells/mL, and missing and !70 g/L, у70 g/L, and missing, respectively). Breast milk Na/K ratio and breast milk HIV load, each measured at 6 weeks and at 3 and 6 months, and the interaction term between these 2 variables were entered as timedependent variables. Infants who never had a positive HIV test were censored at the age of their last negative HIV test.
RESULTS
At baseline, MBF mothers were more likely to have an infant with an Apgar score !9 and to have had breast problems during the first 3 months postpartum (Table 1) . EBF mothers were more likely to have attended school for у8 years, to be multiparous, and to have breast-fed their infant within 1 h of birth. After controlling for (1) having an infant with an Apgar score !9 (who might not have been able to breast-feed within 1 h of birth), (2) participation in the infant feeding counseling intervention, and (3) primiparity and maternal education, mothers who initiated breast-feeding within 1 h of delivery were more likely to EBF to 3 months (adjusted odds ratio [OR], 1.62; 95% confidence interval [CI], 1.02-2.58). The prevalence of mastitis (breast milk Na/K ratio 10.6) at 6 weeks and at 3 and 6 months was 29.1%, 18.4%, and 12.7%, respectively. Using logistic regression for predictors of mastitis at a given visit, the only variables in our data set that were retained at a P value р.1 were primiparity (OR, 1.54; 95% CI, 0.99-2.34) and maternal baseline CD4 count (OR per increase of 100 cells, 0.87; 95% CI, 0.79-0.96). Other variables considered but not retained in the model were MBF, low birth weight, previous child death, and any breast problems at current or previous visits.
Using linear regression, we found that log 10 breast milk HIV load was consistently predicted by baseline log 10 maternal blood HIV load and mastitis (Table 2 ). Log 10 cell-free breast milk HIV load was more strongly predicted by mastitis measured at the same visit than mastitis at previous visits. In addition, at the 3-and 6-month visits, an interaction term for log 10 maternal blood HIV load and mastitis was significantly predictive of log 10 milk HIV load. This interaction represents a higher increase in breast milk HIV load relative to maternal blood HIV load for mothers with a Na/K ratio 10.60. MBF was retained in our 6-week model for log breast milk HIV load on the basis of a NOTE. All mothers included in this table had tested positive for HIV at baseline, and all infants included in this table had tested negative for HIV at 6 weeks of age. CI, confidence interval; EBF, exclusive breast-feeding; K, potassium; MBF, mixed breast-feeding; NA, sodium; OR, odds ratio. significance of , and because it was a key variable of P ! .10 interest, we forced it into the other models presented in Table  2 . MBF was not associated with log 10 milk HIV load or mastitis (Table 3 , unadjusted analysis); However, it was associated with increased HIV transmission (Table 4 ; OR, 2.50),
Mastitis remained strongly predictive of postnatal transmission in the final survival model for postnatal transmission by 12 months (Table 4) . However, maternal plasma HIV load modified the effect of mastitis. When plasma HIV load was high, mastitis was associated with increased transmission; when plasma HIV load was low, the association disappeared. To clarify how plasma HIV load modified the effect of mastitis on postnatal transmission, we constructed separate models for each quartile of log 10 plasma HIV load (Table 5) . Proceeding from the lowest quartile to the highest, the OR for postnatal transmission associated with mastitis increased from 0.26 to 3.05. Furthermore, these estimates for the effect of mastitis remained stable in the full model (Table 5) , even if we exclude mothers with "extreme" but plausible log 10 plasma HIV loads (ie, undetectable and those greater than either 5.5 or 6.0 log 10 copies/mL). Parameters offered but not retained in the transmission models at the level of included the maternal P p .10 factors of age, primiparity, previous infant death, mid-upper arm circumference, and death and the infant factors of birth weight !2500 g, Apgar score !9, and length and head circumference at birth. In addition to offering breast milk Na/K ratio and log 10 breast milk HIV load as time-dependent variables, we offered individual visit values to the model. Breast milk Na/ K ratio or breast milk log 10 HIV load at any particular time postpartum were not as strongly predictive of transmission as were the time dependent values (ie, the breast milk Na/K ratio or breast milk log 10 HIV load most immediately preceding postnatal transmission).
DISCUSSION
In this study, we examined risk factors for postnatal transmission of HIV, including maternal mastitis, breast-feeding exclusivity, breast milk HIV load, and maternal plasma HIV load. MBF was not associated with either mastitis or breast milk HIV load. Mastitis was directly associated with breast milk HIV load; the effect increasing with maternal plasma HIV load. Mastitis was associated with postnatal transmission only when maternal plasma HIV load was high (13.7 log 10 copies/mL).
MBF was associated with postnatal transmission, but this effect was independent of maternal plasma HIV load, breast milk HIV load, and breast milk Na/K ratio. The size of the effect, although of borderline significance in this analysis using a subgroup, is almost identical to that previously published with the full dataset, when the results were highly statistically significant [3] . Moreover, the OR for postnatal transmission among MBF versus EBF mothers remained stable even after adjusting for milk HIV load, mastitis, the interaction between milk HIV load and mastitis, and plasma HIV load-all covariates that were not available for the analysis using the full dataset in the previous publication [3] . These findings suggest that although MBF is associated with postnatal transmission, it does not exert its deleterious effect via changes in the prevalence of mastitis or via changes in breast milk HIV load. Alternative mechanisms may be that MBF influences the immunological competence of breast milk or the infant's ability to resist the virus [4, 9] . Although large reductions in milk consumption by infants are associated with mastitis [10] , the reduction in milk demand by an infant attributable to MBF may not be large enough to cause mastitis.
We found, as has been reported elsewhere [5, 14, 26, 29] , that mastitis is associated with increased breast milk HIV load. In addition, we found an interaction between mastitis and maternal plasma HIV load such that, as maternal plasma HIV load increased, the effect of mastitis on milk HIV load increased. This new finding is consistent with the hypothesis that the increase in breast milk HIV load associated with mastitis may be the result of more than just passive leakage of virus through mammary epithelial tight junctions [30] .
The interaction between mastitis and maternal plasma HIV load is also associated with transmission; the odds of transmission due to mastitis became larger as plasma HIV load increased. Mastitis has previously been reported to be associated with increased postnatal transmission [5, 14] , which was also true in our analyses that did not include an interaction term for mastitis and plasma HIV load. This indicates that on average, mastitis was associated with an increased postnatal transmission risk. However, in stratified analyses, the point estimate for the odds of postnatal transmission due to mastitis among women with HIV loads !3.7 log 10 copies/mL was 0.26 (95% CI, 0.04-1.94), implying the possibility of a protective effect of mastitis at low plasma HIV load levels. During mastitis there is an increased production of immune factors in breast milk including a-defensins [18] , which have been shown to reduce breast-feeding transmission, independent of milk HIV load [31] . These factors may, at low levels of maternal plasma HIV load, outweigh the effect of any increase in breast milk HIV load attributable to mastitis. Conversely, when maternal plasma HIV levels are higher, perhaps the increase in HIV load within the milk overwhelms any immune protection induced by mastitis.
A limitation of this study is that infant feeding method was not randomly assigned. It has been suggested that a higher proportion of healthy, compared with unhealthy, mothers may choose EBF. If healthy mothers are less likely to transmit then it may be incorrect to infer that EBF is protective ("reverse causality") [32] . However our EBF mothers did not show signs of being healthier than the MBF mothers (as measured by plasma HIV load, CD4 count, mid-upper arm circumference, or hemoglobin). A second limitation of our study is that we did not measure cell-associated HIV load, a-defensins, or other immune protective factors in breast milk; these present an opportunity for future study to elaborate the factors involved in breast milk transmission of HIV.
In summary, this study confirms that there are many factors that play important roles in breast-feeding-associated transmission of HIV, including maternal plasma HIV load, exclusivity of breast-feeding, mastitis, and breast milk HIV load. Our data suggest that mastitis may not be associated with increased transmission at lower plasma HIV loads. This interaction between plasma HIV load and mastitis is a new finding and may offer some insight into the dynamics of HIV in blood and milk and the potential role of anti-infective factors.
